Pixelgen
Stockholm, SE · Founded 2020 · 45 employees on LinkedIn · 2 known investors
Find your way into Pixelgen
Pixelgen develops DNA-based visualization technology for cell-surface proteomics, enabling nanoscale spatial analysis of immune cell proteins for precision medicine and translational research. The company's Proximity Network Assay platform supports applications in immunology, hematology, and cell therapy diagnostics and therapeutics.
Founders & leadership
SF
Simon FredrikssoninChief Executive Officer
Investors · 2
In the news
VC funding deals: Alloy Robotics, Axle, Treeline, Turnout - InfotechLeadinfotechlead.com · Aug 2026
Flat Capital leads new funding round in life science company Pixelgen Technologies — TradingView Newstradingview.com · Aug 2026Frequently asked questions
- What does Pixelgen do?
- Pixelgen develops DNA-based visualization technology for cell-surface proteomics, enabling nanoscale spatial analysis of immune cell proteins for precision medicine and translational research. The company's Proximity Network Assay platform supports applications in immunology, hematology, and cell therapy diagnostics and therapeutics.
- Who are Pixelgen's investors?
- Pixelgen's investors include Industrifonden, Navigare Ventures.
- Where is Pixelgen headquartered?
- Pixelgen is headquartered in Stockholm, SE.